C. M. Olsen, L. F. Wilson, A. C. Green, N. Biswas, J. Loyalka, D. C

Slides:



Advertisements
Similar presentations
Changes in the pattern of sun-exposure and sun- protection in young children from tropical Australia A. Smith, 1 S.Harrison, 1 M. Nowak, 1 P. Buettner,
Advertisements

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Skin Safety – Skin Cancer May Skin Safety – Skin Cancer About skin cancer What is skin cancer? Skin cancer occurs when skin cells are damaged, for.
Melanoma By Liam Hanrahan. What is Melanoma? Melanoma is the fourth most common cancer, usually appearing as a pigmented skin lesion. Australia has the.
Sun Exposure and Skin Cancer Prevention
Case Study Read page 84.
Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments K. Boswell,1 H. Cameron,1 J.
A 10 year prospective longitudinal follow up study of a UK paediatric transplant population to assess for skin cancer Seow Hoong Foo1, Peter Nightingale2, Paul.
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031  David C.
A Model to Predict the Risk of Keratinocyte Carcinomas
British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018 J.R. Ingram,1 F. Collier,2,3 D. Brown,4.
Laura J. Dixon1,2, Sara M. Witcraft1, Nancye K. McCowan2, & Robert T
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study  Sarah.
Samine M. D. Ruff1; Kristiane A
Validity of the EQ-5D in pemphigus vulgaris and foliaceus patients
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in Hidradenitis Suppurativa Alicia Pavon Blanco,1.
Anatomical Site Differences of Sodium Laurylsulphate Induced Irritation: Randomised controlled trial D Leskur1, J Bukić1, A Petrić1,2, L Zekan1,2, D Rušić1,
Polyomaviruses of the Skin: Integrating Molecular and Clinical Advances in an Emerging Class of Viruses Jessica C. Sheu1*, Jessica Tran1*, Peter L. Rady2,
A.D. Irvine1,2,3 and P. Mina-Osorio4
Sub-Populations of Dermal Skin Fibroblasts Secrete Distinct Extracellular Matrix: Implications for Using Skin Substitutes in the Clinic Ghetti, M., Topouzi,
Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data M.P. Dizon, A.M. Yu, R.K. Singh, J. Wan, M-M.
M. T. Svendsen1,2. ,, M. T. Ernst3. , K. E. Andersen1,2,4, F
R. Mössner. , D. Wilsmann-Theis. , V. Oji. , P. Gkogkolou. , S. Löhr
Cancer is not a risk factor for bullous pemphigoid
Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway Ingrid Snekvik1,2, Tom I L Nilsen1, 3, Pål R Romundstad1,
Lack of Confidence Interval Reporting in Dermatology: A Call to Action
Chuin Ying Ung, Jonathan M. L. White, Ian R
Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy.
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa J.R. Ingram*,
Oxytocin Alleviates Cellular Senescence through Oxytocin Receptor-Mediated ERK/Nrf2 Signalling Si-Young Cho,1 A Young Kim,1 Juewon Kim,1 Dong-Hwa Choi,2.
Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls H. Mochizuki1, 2, M. J. Lavery2, L.
High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of individuals Ulrik C. Winsløw, Børge.
Marked differences in the density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma and the.
Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among.
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials.
Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study P. Theut Riis, O.B. Pedersen,
Th17/Treg imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking, and autoimmune comorbidities B.C.
Cumulative exposure to biologics and risk of cancer in psoriasis patients: a meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom.
Primary paediatric cutaneous mucinoses
M. Mattii1,¶, M. Lovászi2,¶, N. Garzorz3, A. Atenhan1, M. Quaranta1, F
Applying the phenotype approach for rosacea to practice and research
Methotrexate restores the function of peripheral blood Treg cells in psoriasis vulgaris via CD73/AMPK/mTOR pathway Kexiang Yan1,Wen Xu2,#,Yike Huang1,Zhenghua.
K. A. Su,1,2 L. A. Habel,3 N. S. Achacoso,3 G. D. Friedman,3 M. M
Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: A cross-sectional analysis of the National Inpatient Sample.
T. Tzellos1,2; H. Yang3; F. Mu3; B. Calimlim4; J. Signorovitch3
First Evaluation of the Behavioral Addiction Indoor Tanning Screener (BAITS) in a nationwide representative sample K. Diehl, T. Görig, E.W. Breitbart,
Use of emollients and topical glucocorticoids among adolescents with eczema: data from the population-based birth cohort BAMSE S. Lundin,1,2 C.F. Wahlgren,3,4.
A. Al-Janabi1, Z. K. Jabbar-Lopez2, C.E.M. Griffiths1, Z.Z.N. Yiu1
Surgical re-excision versus observation for histologically dysplastic nevi: a systematic review of associated clinical outcomes K.T. Vuong1, J. Walker2,
Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta-analysis Kyoko Miura1*, Catherine M Olsen1*,
An App Supporting Psoriasis Patients Improves Adherence to Topical Treatment: A randomised controlled trial M.T. Svendsen,1,2,3 F. Andersen,1,4 K.H. Andersen,4.
Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? Theodora Kanni,1 Othmar Zenker,2 Maria Habel,2 Niels Riedemann, 2 Evangelos.
Use of the hCONSORT Criteria as a Reporting Standard for Herbal Interventions for Common Dermatoses – A Systematic Review J. Ornelas, MD, MAS 1, E. Routt,
Atopic dermatitis, educational attainment and psychological functioning: a national cohort study Authors: Jevgenija Smirnova1,2, Laura von Kobyletzki1,3,
Prevalence and determinants of seborrhoeic dermatitis in a middle aged and elderly population: the Rotterdam Study M.G.H. Sanders, MD1, L.M. Pardo, MD,
Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the Phase 3 VOYAGE 1 and VOYAGE.
Kaposiform hemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon Yi Ji1, Kaiying Yang1, Suhua Peng1,
Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group Melchers RC1, Willemze.
Patient reported outcome measures for facial skin cancer: a systematic review and evaluation of the quality of their measurement properties Tom Dobbs,
Proposal of a new scoring formula for the DLQI in psoriasis
RCT pilot study comparing localised immersion PUVA with localised narrowband ultraviolet B (NBUVB) for treatment of palmar hand eczema D. Brass1, T.
Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary.
The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review N. Reddy and B.T. Nguyen Department of Dermatology,
Epidemiology of basal and cutaneous squamous cell carcinoma in the United Kingdom : a cohort study Z C Venables123, T Nijsten4, K F Wong2, P Autier5,
Authors: S. Brill1, E. Sprecher2, F. J. D. Smith3, N. Geva4, H
Individuals with filaggrin-related eczema and asthma have increased long-term medication and hospital admission costs P. Soares, 1 K. Fidler, 1 J. Felton,
The prevalence of psychological co-morbidity in people with vitiligo: a systematic review and meta-analysis O. Osinubi, M.J. Grainge, L. Hong, A. Ahmed,
Tschandl P1,2, Argenziano G3, Razmara M4, Yap J4
Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study  Jeanette.
Presentation transcript:

How many melanomas might be prevented if more people applied sunscreen regularly? C.M. Olsen, L.F. Wilson, A.C. Green, N. Biswas, J. Loyalka, D.C. Whiteman Population Health Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia British Journal of Dermatology. DOI: 10.111/bjd.16079

Senior author David Whiteman QIMR Berghofer Medical Research Institute Brisbane, Australia

Introduction What’s already known? Sunscreen prevents sunburn and protects skin cells (including melanocytes) from mutations induced by ultraviolet radiation Prospective cohort studies and one randomised trial suggest regular sunscreen use reduces risk of malignant melanoma (MM) Regular use of sunscreen is uncommon, even in populations residing in areas of high ambient sunlight levels

Methods Objective: To calculate the potential impact fraction (PIF) for MM in the United States (US) and Australia assuming a range of different intervention scenarios intended to increase sunscreen use

Methods The PIF is the proportional difference between the observed number of MM under the prevailing levels of sunscreen use and the number expected under alternative scenarios of higher prevalence of sunscreen use PREVENT Plus Software used to estimate number of potentially preventable MM in Australia and US under various scenarios

Methods Prevalence of sunscreen use in US and Australia sourced from survey data Published MM incidence projections for US Whites and for Australia from 2012 through 2031 were used as the baseline condition, with sunscreen prevalence estimate from national surveys Relative risk for a protective effect of regular sunscreen use from long-term follow-up of the Nambour Skin Cancer Prevention Trial

Scenarios: Model 1: Prevalence of sunscreen use increased by 5% per year over a 10 year period Model 2: 100% of population used sunscreen daily with immediate implementation Model 3: 100% of population used sunscreen daily with a 10 year implementation period Model 4: Model 1, but for age < 75 only

Scenarios: Effect of timing of intervention: Model 5: school age Model 6: working age Model 7: pre-retirement age

Results

Results

Results Under a plausible public-health intervention scenario comprising incremental increases in sunscreen prevalence over a 10-year implementation program, authors estimated that cumulatively to 2031, 231,053 fewer MM would arise in the US white population (PIF 11%) and 28,071 fewer MM would arise in the Australian population (PIF 10%) Theoretical maximum model of sunscreen use: almost 797,000 (PIF 38%) and 96,000 (PIF 34%) MM would be prevented in the US and Australia respectively between 2012-2031

Discussion What does this study add? Under plausible scenarios of increasing prevalence of sunscreen use, cumulative incidence of MM between 2012-2031 could reduce by ~10% in high-incidence populations Monitoring sunscreen use in populations is necessary to inform MM control efforts

L to R: Louise Wilson, Catherine Olsen, David Whiteman, Adele Green The research team L to R: Louise Wilson, Catherine Olsen, David Whiteman, Adele Green

Call for correspondence Why not join the debate on this article through our correspondence section? Rapid responses should not exceed 350 words, four references and one figure Further details can be found here